Measuring Skin Electrical Potential With the Kelvin Probe: Minimizing

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The Scanning Kelvin Probe measures surface electrical potential without actually touching the skin. This is a pilot study to evaluate methods of minimizing noise during Scanning Kelvin Probe measurements. This project will focus specifically on noise arising from physical movement and environmental electrical field.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05597150` - The Exploration of the Regulatory Effect of Magnesium on Intestinal Flora in Healthy Adults	N/A

NCT number	NCT01399879
Study type	Observational
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	February 2011

Measuring Skin Electrical Potential With the Kelvin Probe: Minimizing Noise

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms